Welcome : Guest

ContraVir Pharmaceuticals, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about ContraVir Pharmaceuticals, Inc., which is principally involved in Biopharmaceuticals Business. Illustrated with 9 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

Code: PCP-64126
Price: $450
Company Type: Public
Pages: 11
Date: March 2016
Market Data Tables: 9

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Antivirals......2
Table 1: Antiviral Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for Antiviral Drugs, Monoclonal Antibodies, Vaccines and Others......2
Infectious Disease Drugs......3
Table 2: Infectious Disease Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Antifungals, Antivirals, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......3
No. of Hepatitis B Patients......4
Table 3: No. of Hepatitis B Patients by Country in Eastern Europe (2015) - Percentage Market Share Breakdown by Volume for Hungary, Poland, and Romania......4
Table 4: No. of Hepatitis B Patients by Country in West Europe (2015) - Percentage Market Share Breakdown by Volume for France, Germany, Italy, Netherlands, Spain, United Kingdom, and Others......5
Table 5: No. of Hepatitis B Patients by Region in Europe (2015) - Percentage Market Share Breakdown by Volume for Eastern Europe, and Western Europe......6
Hepatitis B Drugs......7
Table 6: Market Shares of Leading Hepatitis B (Recombinant) Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Engerix (GlaxoSmithKline Plc), and Others......7
Table 7: Market Shares of Leading Hepatitis B Drug Manufacturers by Value Sales in Korea (2014) - Percentage Breakdown for Bemis Company, Inc. (BMS), Bukwang Pharmaceutical Co., Ltd (Levovir), GlaxoSmithKline Plc (Hopsera, Zeffix), Novartis International AG (Sebivo), and Others......8
Table 8: Market Shares of Leading Hepatitis B Drug Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Bemis Company, Inc.(Baraclude), F. Hoffmann-La Roche AG (Pegasys), GlaxoSmithKline Plc (Hepsera, Zeffix), and Novartis International AG (Sebivo)......9
Table 9: Market Shares of Leading Hepatitis B Immune Globulin Manufacturers in China (2014) - Percentage Breakdown by Value for China Biologic Products, Inc., China National Biotec Group (CNBG), Hualan Biological Engineering, Inc., Nanyue Fuel Injection Systems Co., Ltd., Ningbo Boya Medical Equipment Co., Ltd., Shuyang Group, Tonrol Biopharm Co., Ltd., and Others......10